Digital Diagnostics scores $75M to advance AI-backed diagnostic tech


Share post:

AI-enabled diagnostics firm Digital Diagnostics introduced Tuesday it had raised $75 million in a Collection B funding spherical led by KKR.

Different individuals within the increase embrace Cedar Pine, Kinderhook, 8VC, Optum Ventures, OSF Ventures, Gundersen Well being System, Edward-Elmhurst Well being Enterprise Capital and the College of Iowa. 

The corporate, beforehand generally known as IDx, stated the Collection B brings its whole funding pot to greater than $130 million. Digital Diagnostics scooped up $33 million in Collection A financing in 2018. 


The corporate obtained its begin in AI-backed eye care with its IDx-DR system used to detect diabetic retinopathy, which may trigger imaginative and prescient loss and blindness in folks with diabetes. The IDx-DR product obtained FDA De Novo clearance in 2018. 

Two years later, Digital Diagnostics introduced it had acquired 3Derm Methods, an organization that specialised in offering telemedicine for dermatology. Digital Diagnostics now presents two dermatology-focused instruments: DermTriage, which helps suppliers seize and ship pores and skin photos to distant dermatologists, and DermSpot, which makes use of AI to detect some varieties of pores and skin most cancers. The second product is for investigational use solely and has not but been cleared by the FDA.

Digital Diagnostics will use the money from the Collection B to advance its product roadmap, increase distribution and spend money on gross sales and advertising.

“Digital Diagnostics’ AI expertise platform is paving the trail as a normal of care within the healthcare business. We’re targeted on assembly sufferers the place they need to expertise healthcare from main care and value-based care teams to retail brick and mortar places,” the corporate’s cofounder, president and COO Seth Rainford stated in a press release.

“This new funding will assist drive the corporate’s subsequent stage of development as we double down on our AI product pipeline, permitting for industrial scalability for designing and growing AI the appropriate method.”


Google has additionally been exploring utilizing AI for diagnostics. The tech big is growing its personal product for detecting diabetic retinopathy known as Automated Retinal Illness Evaluation, or ARDA. Throughout a March replace on its healthcare instruments, Google stated it’ll proceed analysis on ARDA, now specializing in whether or not images of the surface of the attention might detect issues.

Google can be engaged on an app known as DermAssist aimed toward serving to customers establish pores and skin circumstances.

Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles